21st Apr 2015 06:55
LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC on Tuesday said it expects its full year revenue to be lower year-on-year, in line with its guidance, driven by lower automated revenue and a significant fall in manual revenue.
The company, which provides clinical laboratory diagnostic services, said it expects revenue for the year to the end of March to be GBP45 million, down from GBP52 million a year earlier and in line with the guidance it gave in September, when the group said its revenue would miss expectations due to a low level of net placements.
That low level of net placements has continued into the second half of its financial year, with automated revenue falling and manual revenue all significantly lower, it said.
Gross direct instrument placements for the company fell to 54 in the year, down from 60 a year earlier, with 40 instruments returned in the year, up from 25, giving it a net direct instrument placement figure of 14 compared to 25 in its 2014 financial year.
The company will publish its full-year results on June 23.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
IDH.L